AbbVie (ABBV) Shares Outstanding (2013 - 2026)

AbbVie (ABBV) has 14 years of Shares Outstanding data on file, last reported at $1.8 billion in Q1 2026.

• Quarterly Shares Outstanding rose 4.41% year-over-year to $1.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 4.41% YoY) and the FY2025 annual result came in at $1.8 billion, up 4.17% from the prior year.
• Shares Outstanding held at $1.8 billion in Q1 2026 per ABBV's latest filing, from $1.8 billion in the prior quarter.
• Across five years, Shares Outstanding topped out at $1.8 billion in Q1 2026 and bottomed at $1.8 billion in Q1 2023.
• The 5-year median for Shares Outstanding is $1.8 billion (2023), against an average of $1.8 billion.
• The widest annual swing landed in 2023, when Shares Outstanding slipped 0.17%; it then gained 4.41% in 2026.
• Tracing ABBV's Shares Outstanding over 5 years: stood at $1.8 billion in 2022, then decreased by 0.17% to $1.8 billion in 2023, then declined by 0.06% to $1.8 billion in 2024, then increased by 4.17% to $1.8 billion in 2025, then increased by 0.28% to $1.8 billion in 2026.
• Per Business Quant, the three latest ABBV Shares Outstanding figures stand at $1.8 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.8 billion (Q3 2025).

Peer Comparison